Translational cancer research is key for addressing, understanding and preventing cancer, a worldwide health concern despite the continuous advancement of research and treatment approaches.
TRANSCAN-4 brings together 30 partners from 17 countries with a shared commitment to advancing high-impact translational cancer research. Through cross-national joint calls for proposals and by strengthening international and interregional collaboration, the initiative seeks to foster scientific excellence and provide a sustainable funding model for innovative cancer research projects across Europe and beyond.
Building on a long-standing and successful collaboration started in 2011, TRANSCAN-4 represents the next phase in the collective effort to accelerate the translation of scientific discoveries into meaningful clinical applications for cancer patients.